3 hours Brokers Offer Predictions for APLS Q3 EarningsMarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at William Blair issued their Q3 2024 earnings per share (EPS) estimates for shares of Apellis Pharmaceuticals in a report issued on Wednesday, October 16th. William Blair…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X